Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • LINKAGE BETWEEN HGI AND FAMILY BACKGROUND OF HYPERTENSION

CSIR-NCL Jobs | Rs. 1 Lakh pm Pay | Biotech/Life Science & Microbiology Apply

Protrudin supports axon regeneration in the adult CNS

LINKAGE BETWEEN HGI AND FAMILY BACKGROUND OF HYPERTENSION
  • BiotechToday
  • World

LINKAGE BETWEEN HGI AND FAMILY BACKGROUND OF HYPERTENSION

bioxone November 6, 2020November 6, 2020

Aishila Kar, Amity University Kolkata

Hypertension, along with difficulties like stroke and chronic kidney disease, consumes social and medical wealth. Around 43% of cardiovascular incidents were found to be assigned to hypertension. Haemoglobin glycation index (HGI) is observed to be a convenient measurable indicator to evaluate the individual difference of HbA1c. In the current study, among Chinese individuals, it has been tested the relationship between HGI and the risk of hypertension.

This work was a community-based survey that took place in Longzihu, Bengbu, China. Using a stratified multi-stage cluster sampling method eligible candidates were selected. HGI was measured as “HbA1c-predicted HbA1c” and divided into four parts according to quartile. The following parts were used to evaluate interactive effects: (1) relative excess risk for interaction (RERI); (2) attributable proportion for interaction (AP); and (3) synergy index (SI). Statistical analysis was present using R software.

In this survey, 1777 eligible candidates were selected with an average age was 60.82 ± 11.24 years. 433 subjects (24.4%) among the respondents, were found to have hypertension. From Q1 to Q4, an increase in the prevalence of hypertension of HGI was noticed (p < 0.001). The multivariable logistic model showed that subjects at the highest HGI group had an increased risk of being hypertensive than the first quartile of HGI, as indicated by the OR value of 1.87. Again, a significant interaction between family background of hypertension and HGI on hypertension risk was noticed. The interactive effect between abdominal obesity and HGI was also found to be important. 

In conclusion, high HGI was independently related to the risk of hypertension. Moreover, HGI significantly shared interactions with obesity and family background of hypertension that increased the risk of hypertension. For now, exploring the processes that cause variation of HbA1c levels may introduce effective novel plans in the early stoppage of hypertension and low blood pressure.

SOURCE- Association of haemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: a community-based cross-sectional survey Jing Mi1†, Jian Song1†, Yingying Zhao2 and Xuesen Wu

Mi et al. BMC Cardiovasc Disord (2020) 20:477 https://doi.org/10.1186/s12872-020-01762-0

https://link.springer.com/epdf/10.1186/s12872-020-01762-0?sharing_token=NkpReFiZvCMGWYdRlYRCVm_BpE1tBhCbnbw3BuzI2RN8G4VY2DCtQD9N80gJheAeYQ6oyyXaL8sqnMBHdrmhW2-CVDgSqhDY30y6kd3NZZlBz915p7Zi6c-UB0b65YINDWDHXP2GMf8Cf_pUrmzxBakoiMxV9zqoLldSs55MO6k%3D

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged Abnormal obesity Blood pressure China disease Hemoglobin glycation index Hypertension hypertension risk interaction medical wealth R software social wealth

2 thoughts on “LINKAGE BETWEEN HGI AND FAMILY BACKGROUND OF HYPERTENSION”

  1. Pingback: Protrudin supports axon regeneration in the adult CNS - BioXone
  2. Pingback: GLUTEN-FREE PRODUCTS MORE HEALTHY? - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Protrudin supports axon regeneration in the adult CNS

bioxone November 6, 2020

Saptaparna Pal, Amity University Kolkata Axons of the adult peripheral nervous system(PNS) and immature central nervous system (CNS) neurons readily regenerate after injury. In addition to the non-permissive extracellular environment after injury, the intrinsic neuronal factors also play an important role in the regenerative failure that is observed in mature CNS neurons. Protrudin acts as […]

Protrudin

Related Post

  • BiotechToday
  • World

Enzyme activity studied under new lens!

bioxone August 2, 2021August 1, 2021

Shenade Annie Kerketta, Amity University Kolkata The knowledge that we have about how an enzyme works is through studying its ACTIVE SITE. New technology has been developed that gives us information about an enzyme by studying beyond the active site. The new technology is called HIGH THROUGHPUT MICROFLUIDIC ENZYME KINETICS (HT-MEK). This technology combines two […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19: Extracorporeal carbon dioxide removal as rescue therapy in severe Covid-19 pneumonitis

bioxone September 26, 2020September 26, 2020

  Srilagna Sarkar, Amity University Kolkata Coronavirus disease 2019, was first identified in Wuhan where 27 patients cases reported of pneumonia of some unknown aetiology were linked with an open seafood market. Despite several measures, the virus spread rapidly and by 11 March 2020 WHO declared it as a global pandemic. In the majority of patients […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

COVID UPDATE: Russian Vaccine enters Phase III trials: A Sputnik moment or a Russian Roulette?

bioxone September 27, 2020September 27, 2020

Team BioXone Covid-19 continues to spread globally like wildfire. The vaccine in development is the only hope for prevention and containment. Every capable country is into investing millions to fast track development of vaccines, telescoping the duration of clinical trials from years to months. Russia launched its home-brewed vaccine – SPUTNIK V, in August, based […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy